| Bernard Cieniawa, DO | |
|
24 Hospital Ave, Danbury, CT 06810-6099 | |
| (203) 797-7405 | |
| (203) 731-8049 |
| Full Name | Bernard Cieniawa |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 24 Hospital Ave, Danbury, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457384653 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 000175 (Connecticut) | Primary |
| Entity Name | Norwalk Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427041581 PECOS PAC ID: 3375436660 Enrollment ID: O20040202000988 |
News Archive
Genta Incorporated today announced that the Company has initiated a new Phase 2 clinical trial of tesetaxel in patients with advanced bladder cancer. Tesetaxel is the leading oral taxane in clinical development. The new trial will be conducted at Memorial Sloan-Kettering Cancer Center, New York, NY, the Kimmel Cancer Center at Jefferson University, Philadelphia, PA, and at least one site in the EU.
Sleep disorders are often the first sign of serious neurological diseases. Neurologists should inquire extensively about the quality of their patients' sleep.
The unprecedented growth and promise of using thermal ablation to target and kill cancer is the subject of the Journal of Vascular and Interventional Radiology's August supplement, "Thermal Ablation 2010 At the Crossroads of Past Success, Current Goals and Future Technology."
In patients with non-ST-elevation acute coronary syndrome (NSTE- ACS), pre-treatment with the P2Y12 antagonist prasugrel prior to catheterization, significantly increases the risk of life-threatening bleeding without reducing the risk of major ischemic events, according to the results of the ACCOAST (A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction) trial.
NPR's "Shots" blog reports on one of the drug trials considered by the FDA in its approval of the antiretroviral drug Truvada for pre-exposure prophylaxis (PrEP) to prevent HIV among people at risk of contracting the virus, which "was done at the Oswaldo Cruz Foundation Research Institute, also known as Fiocruz, in Rio de Janeiro."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bernard Cieniawa, DO 16 Oak Ridge Dr, Newtown, CT 06470-2457 Ph: (203) 270-8116 | Bernard Cieniawa, DO 24 Hospital Ave, Danbury, CT 06810-6099 Ph: (203) 797-7405 |
News Archive
Genta Incorporated today announced that the Company has initiated a new Phase 2 clinical trial of tesetaxel in patients with advanced bladder cancer. Tesetaxel is the leading oral taxane in clinical development. The new trial will be conducted at Memorial Sloan-Kettering Cancer Center, New York, NY, the Kimmel Cancer Center at Jefferson University, Philadelphia, PA, and at least one site in the EU.
Sleep disorders are often the first sign of serious neurological diseases. Neurologists should inquire extensively about the quality of their patients' sleep.
The unprecedented growth and promise of using thermal ablation to target and kill cancer is the subject of the Journal of Vascular and Interventional Radiology's August supplement, "Thermal Ablation 2010 At the Crossroads of Past Success, Current Goals and Future Technology."
In patients with non-ST-elevation acute coronary syndrome (NSTE- ACS), pre-treatment with the P2Y12 antagonist prasugrel prior to catheterization, significantly increases the risk of life-threatening bleeding without reducing the risk of major ischemic events, according to the results of the ACCOAST (A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction) trial.
NPR's "Shots" blog reports on one of the drug trials considered by the FDA in its approval of the antiretroviral drug Truvada for pre-exposure prophylaxis (PrEP) to prevent HIV among people at risk of contracting the virus, which "was done at the Oswaldo Cruz Foundation Research Institute, also known as Fiocruz, in Rio de Janeiro."
› Verified 2 days ago
Dr. Andrew Caligiuri, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-7000 | |
Jacob Bartel Lotstein, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-7100 | |
Dr. Andrew L. Webber, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury Hospital - Dept. Of Emergency Medicine, Danbury, CT 06810 Phone: 203-739-7101 Fax: 203-739-8049 | |
James Lunan, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7100 | |
Dr. Benjamin Lawrence Kliot, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-7447 | |
Dr. Samuel Jones Ii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 24 Hospital Ave, Danbury Hospital, Danbury, CT 06810 Phone: 203-739-7000 | |
Patrick Broderick, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7100 |